Latin America Pharmaceutical Products CMO Market, by Product Type (API and Ingredients, Finished Dosage Form, and Pharmaceutical Packaging) and by Country (Brazil, Mexico, Argentina, and Rest of Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Feb 2021

Code : CMI3933

Pages :151

Formats :

Excel and PDF

Industry : Pharmaceutical

Leading Companies

Major players in the market are also focused on R&D of new products to expand their product portfolio. For instance, in December 2019, FerGene, a new gene therapy company formed as an alliance between Ferring Pharmaceuticals and Blackstone Life Sciences, announced positive results from a clinical trial that assessed the efficacy of nadofaragene firadenovec (rAd-IFN/Syn3), an investigational gene therapy, for the treatment of high-grade, Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer.

Key Players

Major players operating in the Latin America pharmaceutical products CMO market include BASF SE, Bayer AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Pisa Farmacéutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, Inc., and Landsteiner Scientific